CANNAPHARMARX, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-6.6K | $-1.0M | $-11.7M | $-4.0M | $-94.4K | $-98.1K | $-99.7K | $575.4K |
| Depreciation & Amortization | — | — | — | $0 | — | — | — | — |
| Depreciation | $0 | $0 | $12.0K | $3.0K | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $0 | $728.1K | $7.4M | $579.6K | — | — | — | — |
| Net Cash from Operating Activities | $0 | $-22.4K | $-2.5M | $-1.5M | $-11.0K | $-10.9K | $-12.1K | $0 |
| Investing Activities | ||||||||
| Capital Expenditures | — | $0 | $2.1K | $100.7K | — | — | — | — |
| Business Acquisitions | $0 | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $0 | $135.7K | $-150.7K | — | — | — | $100 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $19.8K | $810.5K | $3.3M | — | $10.9K | $12.0K | $60.0K |
| Net Change in Cash | $0 | $-2.6K | $-1.6M | $1.6M | $-25 | $0 | $-75 | $100 |
| Free Cash Flow | — | $-22.4K | $-2.6M | $-1.6M | — | — | — | — |